InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: jondoeuk post# 273

Thursday, 05/11/2023 10:34:29 PM

Thursday, May 11, 2023 10:34:29 PM

Post# of 386
CGEM MICA/B good enough for a poster. So much for the pan cancer claim. Not good news for NKTX.
A phase 1 dose-escalation study to investigate the safety, efficacy, pharmacokinetics, and pharmacodynamic activity of cln-619 (Anti-MICA/B antibody) alone and in combination with pembrolizumab in patients with advanced solid tumors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News